Patient Care

Fluvastatin Improves Postoperative Cardiac Outcomes in Patients Undergoing Vascular Surgery


Clinical question: Does perioperative fluvastatin decrease adverse cardiac events after vascular surgery?

Background: Patients with atherosclerotic vascular disease who undergo vascular surgery are at high risk for postoperative cardiac events. Studies in nonsurgical populations have shown the beneficial effects of statin therapy on cardiac outcomes. However, no placebo-controlled trials have addressed the effect of statins on postoperative cardiac outcomes.

Study design: Randomized, double-blind, placebo-controlled trial.

Setting: Single large academic medical center in the Netherlands.

Synopsis: The study looked at 497 statin-naïve patients 40 years or older undergoing non-cardiac vascular surgery. The patients were randomized to 80 mg of extended-release fluvastatin versus placebo; all patients received a beta-blocker. Therapy began preoperatively (median of 37 days) and continued for at least 30 days after surgery. Outcomes were assessed at 30 days post-surgery.

Postoperative myocardial infarction (MI) was significantly less common in the fluvastatin group than with placebo (10.8% vs. 19%, hazard ratio (HR) 0.55, P=0.01). In addition, the treatment group had a lower frequency of death from cardiovascular causes (4.8% vs. 10.1%, HR 0.47, P=0.03). Statin therapy was not associated with an increased rate of adverse events.

Notably, all of the patients enrolled in this study were high-risk patients undergoing high-risk (vascular) surgery. Patients already on statins were excluded.

Further studies are needed to determine whether the findings can be extrapolated to other populations, including nonvascular surgery patients.

Bottom line: Perioperative statin therapy resulted in a significant decrease in postoperative MI and death within 30 days of vascular surgery.

Citation: Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361(10):980-989.

Recommended Reading

High Perioperative Oxygen Fraction Does Not Improve Surgical-Site Infection Frequency after Abdominal Surgery
The Hospitalist
Diabetes Mellitus Does Not Increase Risk of Surgical Complications after Elective Total Knee Replacement Surgery
The Hospitalist
Early Surgery Might Not Provide Survival Benefit in All Patients with Prosthetic Valve Endocarditis
The Hospitalist
Frailty Indices Tool Predicts Post-Operative Complications, Mortality after Elective Surgery in Geriatric Patients
The Hospitalist
Pre-Operative Use of Angiotension Converting Enzyme Inhibitors, Angiotension Receptor Blockers Examined in Elective Joint Replacement Surgery
The Hospitalist
Hospital-Based Palliative Care Reduces Length of Stay, Charges, Invasive Procedures, ICU Deaths
The Hospitalist
Reviews of Research on Steroids and VTE Risk, Epidural Catheterization, and Beta-Blockers During Noncardiac Surgery
The Hospitalist
Acute-Care Surgery Hospitalists: Coming to a Medical Center Near You?
The Hospitalist
Pre-Operative Angiotensin Axis Blockade Increases Risk of Hypotension, Acute Kidney Injury with Major Orthopedic Surgery
The Hospitalist
What Patients Undergoing Gastrointestinal Endoscopic Procedures Should Receive Antibiotic Prophylaxis?
The Hospitalist
   Comments ()